BLEOMYCIN (BLEOMYCIN SULFATE) — all Canadian products
4 DINs
3 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is BLEOMYCIN (BLEOMYCIN SULFATE), with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02265982 | BLEOMYCIN FOR INJECTION | FRESENIUS KABI CANADA LTD | Powder For Solution | Subcutaneous; Intramuscular; Intravenous; Intrapleural | BLEOMYCIN (BLEOMYCIN SULFATE) 15 UNIT | Marketed | |
| 02566346 | BLEOMYCIN FOR INJECTION | MARCAN PHARMACEUTICALS INC | Powder For Solution | Subcutaneous; Intrapleural; Intravenous; Intramuscular | BLEOMYCIN (BLEOMYCIN SULFATE) 15 UNIT | Approved | |
| 02131692 | BLEOMYCIN FOR INJECTION USP | PFIZER CANADA ULC | Powder For Solution | Intracavitary; Intramuscular; Subcutaneous; Intra-Arterial; Intravenous | BLEOMYCIN (BLEOMYCIN SULFATE) 15 UNIT | Marketed | |
| 02367351 | BLEOMYCIN FOR INJECTION USP | SANDOZ CANADA INCORPORATED | Powder For Solution | Intravenous; Intrapleural; Intramuscular; Subcutaneous | BLEOMYCIN (BLEOMYCIN SULFATE) 15 UNIT | Cancelled Pre Market |
Browse other molecules: